Zimmer Biomet Holdings Inc (ZBH) 13F Holders & Ownership Data (915 Funds, Q2 2026)

ZBH ranks #545 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

ZBH is a disclosed holding of Bill Nygren (Harris Associates L.P.), one of the tracked superinvestors on AlphaSMO — it makes up 1.4% of that fund's own 13F portfolio.

915 institutions disclose a position in ZBH, but none treat it as a major bet — even Vestal Point Capital, LP, its most concentrated holder, allocates just 2.8% of its own portfolio to it.

ASR Vermogensbeheer N.V. has added to its ZBH position for two straight quarters, increasing it by $2.9M to reach $5.0M today.

Douglas Lane & Associates, LLC has trimmed its ZBH position for two straight quarters, cutting it by $2.8M while still holding $40.1M.

ZBH is down 0.3% today, but institutions show net buying of $2.8B this quarter — a divergence between today's price move and the underlying institutional flow.

ZBH posted net income of $806.6M over the trailing twelve months, and currently trades at a P/E of 22.6.

• Profitable — net income of $806.6M over the trailing twelve months
• Revenue grew 8.6% year over year
• Net income declined year over year, from $823.4M to $806.6M
• Generated $1.7B in positive operating cash flow
• Current ratio of 1.98x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.82x equity — within a conventional range